Literature DB >> 34673252

Chemically induced models of Parkinson's disease.

Thilaga Thirugnanam1, Kirankumar Santhakumar2.   

Abstract

Environmental toxins are harmful substances detrimental to humans. Constant exposure to these fatal neurotoxins can cause various neurodegenerative disorders. Although poisonous, specific neurotoxins at optimal concentrations mimic the clinical features of neurodegenerative diseases in several animal models. Such chemically-induced model systems are beneficial in deciphering the molecular mechanisms of neurodegeneration and drug screening for these disorders. One such neurotoxin is 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a widely used chemical that recapitulates Parkinsonian features in various animal models. Apart from MPTP, other neurotoxins like 6-hydroxydopamine (6-OHDA), paraquat, rotenone also induce specific clinical features of Parkinson's disease in animal models. These chemically-induced Parkinson's disease models are playing a crucial role in understanding Parkinson's disease onset, pathology, and novel therapeutics. In this review, we provide a concise overview of various neurotoxins that can recapitulate Parkinsonian features in different in vivo and in vitro model systems specifically focusing on the different treatment methodologies of neurotoxins.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C. elegans; Drosophila; Neurotoxicity; Primate; Rodent; Zebrafish

Mesh:

Substances:

Year:  2021        PMID: 34673252     DOI: 10.1016/j.cbpc.2021.109213

Source DB:  PubMed          Journal:  Comp Biochem Physiol C Toxicol Pharmacol        ISSN: 1532-0456            Impact factor:   3.228


  3 in total

1.  Alpha-Mangostin Alleviates the Short-term 6-Hydroxydopamine-Induced Neurotoxicity and Oxidative Damage in Rat Cortical Slices and in Caenorhabditis elegans.

Authors:  Rubén Estrada-Valencia; María Ester Hurtado-Díaz; Edgar Rangel-López; Socorro Retana-Márquez; Isaac Túnez; Alexey Tinkov; Cimen Karasu; Beatriz Ferrer; José Pedraza-Chaverri; Michael Aschner; Abel Santamaría
Journal:  Neurotox Res       Date:  2022-04-05       Impact factor: 3.911

2.  Taste Impairments in a Parkinson's Disease Model Featuring Intranasal Rotenone Administration in Mice.

Authors:  Dong Xu Yin; Hiroki Toyoda; Kazunori Nozaki; Keitaro Satoh; Ayano Katagiri; Kazunori Adachi; Takafumi Kato; Hajime Sato
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 3.  Demystifying the Neuroprotective Role of Neuropeptides in Parkinson's Disease: A Newfangled and Eloquent Therapeutic Perspective.

Authors:  Tapan Behl; Piyush Madaan; Aayush Sehgal; Sukhbir Singh; Hafiz A Makeen; Mohammed Albratty; Hassan A Alhazmi; Abdulkarim M Meraya; Simona Bungau
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.